共 50 条
[33]
90Y-ibritumomab treatment for relapsed and/or refractory B cell type non-Hodgkin's lymphoma.: Multiinstitutional Argentinian study
[J].
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL,
2007, 92
:111-111
[38]
Ibritumomab tiuxetan (Zevalin) for non-Hodgkin's lymphoma
[J].
MEDICAL LETTER ON DRUGS AND THERAPEUTICS,
2002, 44 (1144)
:101-102